TENAX THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
TENAX THERAPEUTICS, INC. (TENX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.29 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-07-31
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 22.50K shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.26M shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 160.00K shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 400.00K shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 3.49M shares, a 11.65% increase from fiscal 2024.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.13M shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 3.64M shares, a 227976.61% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 22.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | 1.29M shares 10-Q · filed 2026-07-31 | 1.45M shares derived: sum of 3 quarters · filed 2026-07-31 | 1.85M shares derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | 1.26M shares 10-Q · filed 2026-05-12 | 1.42M shares derived: sum of 2 quarters · filed 2026-05-12 | 1.82M shares derived: sum of 3 quarters · filed 2026-05-12 | |
| 2025-12-31 | 160.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 560.00K shares derived: sum of 2 quarters · filed 2026-03-10 | 3.49M shares 10-K · filed 2026-03-10 | |
| 2025-09-30 | 400.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 3.33M shares 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | 2.93M shares 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | 3.13M shares 10-K · filed 2026-03-10 | |||
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-25 | |||
| 2016-09-30 | 60.00K shares 10-Q · filed 2016-11-09 | |||
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-10 | |||
| 2015-10-31 | 25.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | 85.05K shares 10-Q · filed 2015-12-10 | ||
| 2015-07-31 | 60.05K shares 10-Q · filed 2015-09-09 | |||
| 2015-01-31 | 50.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | 175.00 shares derived: sum of 2 quarters · filed 2015-03-17 | 50.23K shares 10-Q · filed 2015-03-17 | 3.65M shares derived: sum of 4 quarters · filed 2015-03-17 |
| 2014-10-31 | 125.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | 50.17K shares 10-Q · filed 2014-12-15 | 3.65M shares derived: sum of 3 quarters · filed 2014-12-15 | 3.65M shares derived: sum of 4 quarters · filed 2014-12-15 |
| 2014-07-31 | 50.05K shares 10-Q · filed 2014-09-15 | 3.65M shares derived: sum of 2 quarters · filed 2014-09-15 | 3.65M shares derived: sum of 3 quarters · filed 2014-09-15 | 3.65M shares derived: sum of 4 quarters · filed 2014-09-15 |
| 2014-04-30 | 3.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-29 | 3.60M shares derived: sum of 2 quarters · filed 2014-07-29 | 3.60M shares derived: sum of 3 quarters · filed 2014-07-29 | 3.64M shares 10-K · filed 2014-07-29 |
| 2014-01-31 | 50.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | 175.00 shares derived: sum of 2 quarters · filed 2014-03-17 | 39.94K shares 10-Q · filed 2014-03-17 | 10.65K shares derived: sum of 4 quarters · filed 2014-07-29 |
| 2013-10-31 | 125.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-17 | 39.89K shares 10-Q · filed 2013-12-17 | 10.60K shares derived: sum of 3 quarters · filed 2014-07-29 | 11.60K shares derived: sum of 4 quarters · filed 2014-07-29 |
| 2013-07-31 | 39.77K shares 10-Q · filed 2013-09-17 | 10.47K shares derived: sum of 2 quarters · filed 2014-07-29 | 11.47K shares derived: sum of 3 quarters · filed 2014-07-29 | 13.97K shares derived: sum of 4 quarters · filed 2014-07-29 |
| 2013-04-30 | -29.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-29 | -28.30K shares derived: sum of 2 quarters · filed 2014-07-29 | -25.80K shares derived: sum of 3 quarters · filed 2014-07-29 | 1.59K shares 10-K · filed 2014-07-29 |
| 2013-01-31 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | 3.50K shares derived: sum of 2 quarters · filed 2013-03-18 | 30.89K shares 10-Q · filed 2013-03-18 | |
| 2012-10-31 | 2.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | 29.89K shares 10-Q · filed 2012-12-14 | ||
| 2012-07-31 | 27.39K shares 10-Q · filed 2012-09-19 | |||
| 2012-04-30 | 5.37K shares 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |